The Diversification Crisis in Manufacturing November 12, 2020 According to a survey conducted by ISM, 75 percent of U.S. manufacturing companies experienced delayed resources and materials due to the COVID-19 pandemic. The outbreak has forced manufacturers to rethink supply chains to allow for product diversification.
Manufacturing Adds 38,000 Jobs in October November 6, 2020 Manufacturing added 38,000 jobs in October, with a majority in durable goods, the Bureau of Labor Statistics said today.
Hexagon Acquires DP Technology Corp., Developer of ESPRIT CAM Software October 29, 2020 Hexagon AB, a developer of sensor, software and autonomous solutions announced the signing of an agreement to acquire DP Technology Corp., developer of the ESPRIT CAM System.
Willemin-Macodel Gets Machine-Optimized ESPRIT CAM Solutions October 12, 2020 Engineers at DP Technology Corp. developed highly optimized support for Willemin-Macodel within its ESPRIT CAM
SPR Machine Discovers New Productivity in Brass October 9, 2020 Three partners contributed their diverse manufacturing and machining experience—and their last initials—to found SPR Machine in 2002.
It’s Time to Industrialize Hypersonic Weaponry October 8, 2020 The U.S. Department of Defense (DoD) wants the industry to secure the country’s leadership in hypersonic weaponry. The request is no small feat.
How Manufacturers Can Build More Efficient Health Plans September 21, 2020 An executive makes the case for why manufacturers may want to change how they procure health plans.
Report: M&A in Precision Manufacturing Industry Remains High September 21, 2020 Capstone Headwaters released its Precision Manufacturing Mergers & Acquisitions (M&A) Update Sept. 17, reporting that transaction activity in the precision manufacturing industry has remained strong despite the pandemic.
Deloitte, Wichita State Launch New Smart Factory September 16, 2020 Deloitte and Wichita State University announced the launch of The Smart Factory @ Wichita,
In the thick of the ‘herculean’ vaccine push September 21, 2020 In January, as the new coronavirus was rapidly spreading around the world, scientists at Moderna teamed up with the National Institutes of Health to pursue a potential vaccine based on an experimental genetic technology involving messenger RNA (mRNA), a molecule in every cell that helps translate DNA into biological functions.
